VRTX · Vertex Pharmaceuticals Incorporated Common Stock
View on chartInsiders & Stakes
| Reshma Kewalramani Director | ▼ Sell | Open Market | 98,278 Shares held | 2/27/2026 | View profile |
| Amit Sachdev EVP, Chief Patient Officer | ▲ Buy | Grant | 66,512 Shares held | 7/21/2026 | View profile |
| Stuart A. Arbuckle Director | ▼ Sell | Tax Withholding | 63,368 Shares held | 7/1/2025 | View profile |
| Ourania Tatsis EVP, Chief Reg. & Quality Off. | ▲ Buy | Grant | 53,572 Shares held | 7/21/2026 | View profile |
| Charles F. Wagner Jr. EVP & Chief Financial Officer | ▼ Sell | Tax Withholding | 47,042 Shares held | 2/24/2026 | View profile |
| SACHS BRUCE I Director | ▼ Sell | Gift | 39,000 Shares held | 8/27/2026 | View profile |
| LEIDEN JEFFREY M Executive Chairman | ▼ Sell | Tax Withholding | 34,797 Shares held | 2/24/2026 | View profile |
| ALTSHULER DAVID EVP, Global Research and CSO | ▲ Buy | Grant | 34,477 Shares held | 1/22/2026 | View profile |
| Sanna Bastiano EVP, Cell & Genetic Therapies | ▼ Sell | Open Market | 32,038 Shares held | 5/8/2023 | View profile |
| Joy Liu SVP, General Counsel | ▼ Sell | Open Market | 19,131 Shares held | 7/1/2026 | View profile |
| Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | ▼ Sell | Open Market | 18,432 Shares held | 2/25/2026 | View profile |
| Carmen Bozic EVP and CMO | ▼ Sell | Open Market | 15,337 Shares held | 6/26/2026 | View profile |
| Biller Jonathan Chief Financial Officer | ▼ Sell | Open Market | 13,659 Shares held | 2/25/2026 | View profile |
| Kristen Ambrose SVP & Chief Accounting Officer | ▲ Buy | Grant | 11,624 Shares held | 8/28/2026 | View profile |
| Duncan McKechnie EVP, Chief Commercial Officer | ▼ Sell | Open Market | 11,001 Shares held | 7/2/2026 | View profile |
| van Grunsven Jasper EVP, CP and NPPO | ▲ Buy | Grant | 8,682 Shares held | 9/8/2026 | View profile |
| Alan M. Garber Director | ▲ Buy | Grant | 7,344 Shares held | 5/1/2026 | View profile |
| Mark E. Bunnage EVP, Chief Scientific Officer | ▼ Sell | Open Market | 7,284 Shares held | 5/15/2026 | View profile |
| Kearney Terrence C Director | ▼ Sell | Open Market | 6,536 Shares held | 8/10/2023 | View profile |
| Lloyd Carney Director | ▼ Sell | Gift | 6,315 Shares held | 11/19/2025 | View profile |
| Sangeeta N. Bhatia Director | ▼ Sell | Open Market | 4,924 Shares held | 5/4/2026 | View profile |
| Diana McKenzie Director | ▼ Sell | Other | 2,378 Shares held | 5/1/2026 | View profile |
| Nancy Thornberry Director | ▼ Sell | Other | 2,109 Shares held | 5/1/2026 | View profile |
| Lee Yuchun Director | ▼ Sell | Open Market | 1,875 Shares held | 1/27/2023 | View profile |
| Suketu Upadhyay Exec. VP, CFO | ▼ Sell | Other | 1,558 Shares held | 5/1/2026 | View profile |
| Jennifer Schneider Director | ▼ Sell | Other | 1,394 Shares held | 5/1/2026 | View profile |
| Michel Lagarde Executive Vice President & COO | ▲ Buy | Grant | 1,132 Shares held | 10/5/2023 | View profile |
| MCGLYNN MARGARET G Director | ▼ Sell | Other | 178 Shares held | 5/1/2022 | View profile |
Transaction History
| van Grunsven Jasper | ▲ Buy | Grant | 8,682 | $0 | 9/8/2026 |
| Kristen Ambrose | ▲ Buy | Grant | 5,000 | $0 | 8/28/2026 |
| SACHS BRUCE I | ▼ Sell | Gift | 6,000 | $0 | 8/27/2026 |
| Ourania Tatsis | ▲ Buy | Grant | 8,251 | $0 | 7/21/2026 |
| Amit Sachdev | ▲ Buy | Grant | 8,251 | $0 | 7/21/2026 |
| Ourania Tatsis | ▼ Sell | Open Market | 1,500 | $787K | 7/2/2026 |
| Duncan McKechnie | ▼ Sell | Open Market | 1,541 | $800K | 7/2/2026 |
| Joy Liu | ▼ Sell | Open Market | 828 | $416K | 7/1/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 596 | $288K | 6/26/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 1,020 | $471K | 6/18/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 4,062 | $1.8M | 6/15/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 1,745 | $785K | 6/5/2026 |
| Joy Liu | ▼ Sell | Open Market | 828 | $364K | 6/1/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 1,974 | $888K | 5/29/2026 |
| Mark E. Bunnage | ▼ Sell | Open Market | 33 | $15K | 5/15/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 1,354 | $614K | 5/15/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 6,988 | $3.1M | 5/12/2026 |
| Sangeeta N. Bhatia | ▼ Sell | Open Market | 318 | $135K | 5/4/2026 |
| Suketu Upadhyay | ▼ Sell | Other | 796 | — | 5/1/2026 |
| Nancy Thornberry | ▲ Buy | Grant | 472 | $0 | 5/1/2026 |
| Nancy Thornberry | ▼ Sell | Other | 398 | — | 5/1/2026 |
| Jennifer Schneider | ▲ Buy | Grant | 472 | $0 | 5/1/2026 |
| Jennifer Schneider | ▼ Sell | Other | 796 | — | 5/1/2026 |
| Diana McKenzie | ▲ Buy | Grant | 943 | $0 | 5/1/2026 |
| Diana McKenzie | ▼ Sell | Other | 796 | — | 5/1/2026 |
| Joy Liu | ▼ Sell | Open Market | 1,104 | $469K | 5/1/2026 |
| Alan M. Garber | ▲ Buy | Grant | 472 | $0 | 5/1/2026 |
| Sangeeta N. Bhatia | ▲ Buy | Grant | 943 | $0 | 5/1/2026 |
| Joy Liu | ▼ Sell | Open Market | 978 | $439K | 4/1/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 2,329 | $1.1M | 3/27/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 2,329 | $1.1M | 3/13/2026 |
| Duncan McKechnie | ▼ Sell | Open Market | 2,633 | $1.3M | 3/11/2026 |
| Duncan McKechnie | ▼ Sell | Open Market | 2,437 | $1.2M | 3/4/2026 |
| Joy Liu | ▼ Sell | Open Market | 892 | $442K | 3/2/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 460 | $225K | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 2,725 | $1.3M | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 949 | $466K | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 2,520 | $1.2M | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 3,498 | $1.7M | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 15,580 | $7.7M | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 400 | $192K | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 120 | $58K | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 240 | $116K | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 2,510 | $1.2M | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 3,278 | $1.6M | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 5,995 | $3.0M | 2/27/2026 |
| Reshma Kewalramani | ▼ Sell | Open Market | 1,725 | $857K | 2/27/2026 |
| Carmen Bozic | ▼ Sell | Open Market | 2,329 | $1.1M | 2/27/2026 |
| Kristen Ambrose | ▼ Sell | Open Market | 357 | $173K | 2/26/2026 |
| Ourania Tatsis | ▼ Sell | Open Market | 260 | $126K | 2/25/2026 |
| Kristen Ambrose | ▼ Sell | Open Market | 223 | $108K | 2/25/2026 |
| Biller Jonathan | ▼ Sell | Open Market | 945 | $460K | 2/25/2026 |
| Mark E. Bunnage | ▼ Sell | Open Market | 620 | $302K | 2/25/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 1,846 | $898K | 2/25/2026 |
| Duncan McKechnie | ▼ Sell | Open Market | 2,500 | $1.2M | 2/25/2026 |
| Duncan McKechnie | ▼ Sell | Open Market | 2,410 | $1.2M | 2/25/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Open Market | 668 | $325K | 2/25/2026 |
| Charles F. Wagner Jr. | ▼ Sell | Tax Withholding | 1,744 | $846K | 2/24/2026 |
| Ourania Tatsis | ▼ Sell | Tax Withholding | 1,627 | $789K | 2/24/2026 |
| Reshma Kewalramani | ▼ Sell | Tax Withholding | 4,981 | $2.4M | 2/24/2026 |
| Mark E. Bunnage | ▼ Sell | Tax Withholding | 582 | $282K | 2/24/2026 |
| Carmen Bozic | ▼ Sell | Tax Withholding | 1,453 | $705K | 2/24/2026 |
| Biller Jonathan | ▼ Sell | Tax Withholding | 1,144 | $555K | 2/24/2026 |
| Kristen Ambrose | ▼ Sell | Tax Withholding | 546 | $265K | 2/24/2026 |
| Duncan McKechnie | ▼ Sell | Tax Withholding | 873 | $424K | 2/24/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Tax Withholding | 1,627 | $789K | 2/24/2026 |
| Amit Sachdev | ▼ Sell | Tax Withholding | 1,518 | $736K | 2/24/2026 |
| LEIDEN JEFFREY M | ▼ Sell | Tax Withholding | 3,547 | $1.7M | 2/24/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 2,730 | $1.3M | 2/19/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 19,662 | $9.2M | 2/19/2026 |
| Amit Sachdev | ▲ Buy | Option Exercise | 23,479 | $3.7M | 2/19/2026 |
| Amit Sachdev | ▲ Buy | Option Exercise | 25,026 | $4.7M | 2/19/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 1,848 | $861K | 2/19/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 10,263 | $4.8M | 2/19/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 920 | $427K | 2/19/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 7,241 | $3.4M | 2/19/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 4,237 | $2.0M | 2/19/2026 |
| Amit Sachdev | ▼ Sell | Open Market | 11,712 | $5.5M | 2/19/2026 |
| Biller Jonathan | ▼ Sell | Open Market | 1,244 | $589K | 2/18/2026 |
| Mark E. Bunnage | ▼ Sell | Open Market | 1,182 | $560K | 2/18/2026 |
| Ourania Tatsis | ▼ Sell | Open Market | 368 | $174K | 2/18/2026 |
| LEIDEN JEFFREY M | ▼ Sell | Tax Withholding | 2,964 | $1.4M | 2/18/2026 |
| Kristen Ambrose | ▼ Sell | Open Market | 638 | $302K | 2/18/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Open Market | 817 | $387K | 2/18/2026 |
| Ourania Tatsis | ▼ Sell | Open Market | 609 | $298K | 2/17/2026 |
| Amit Sachdev | ▼ Sell | Tax Withholding | 2,140 | $1.0M | 2/17/2026 |
| Reshma Kewalramani | ▼ Sell | Tax Withholding | 6,554 | $3.2M | 2/17/2026 |
| Mark E. Bunnage | ▼ Sell | Tax Withholding | 1,110 | $537K | 2/17/2026 |
| Biller Jonathan | ▼ Sell | Tax Withholding | 1,505 | $728K | 2/17/2026 |
| Biller Jonathan | ▼ Sell | Open Market | 2,476 | $1.2M | 2/17/2026 |
| Atkinson Edward Morrow III | ▲ Buy | Grant | 4,962 | $0 | 2/17/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Tax Withholding | 1,530 | $740K | 2/17/2026 |
| Biller Jonathan | ▲ Buy | Grant | 4,135 | $0 | 2/17/2026 |
| Duncan McKechnie | ▼ Sell | Tax Withholding | 1,148 | $555K | 2/17/2026 |
| Reshma Kewalramani | ▲ Buy | Grant | 16,326 | $0 | 2/17/2026 |
| Mark E. Bunnage | ▼ Sell | Open Market | 2,437 | $1.2M | 2/17/2026 |
| Mark E. Bunnage | ▲ Buy | Grant | 2,584 | $0 | 2/17/2026 |
| Ourania Tatsis | ▼ Sell | Tax Withholding | 2,294 | $1.1M | 2/17/2026 |
| Carmen Bozic | ▲ Buy | Grant | 5,375 | $0 | 2/17/2026 |
| LEIDEN JEFFREY M | ▲ Buy | Grant | 8,269 | $0 | 2/17/2026 |
| Carmen Bozic | ▼ Sell | Tax Withholding | 1,912 | $925K | 2/17/2026 |
| Duncan McKechnie | ▲ Buy | Grant | 4,962 | $0 | 2/17/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Open Market | 2,031 | $994K | 2/17/2026 |
| Kristen Ambrose | ▲ Buy | Grant | 1,809 | $0 | 2/17/2026 |
| Kristen Ambrose | ▼ Sell | Tax Withholding | 598 | $289K | 2/17/2026 |
| Kristen Ambrose | ▼ Sell | Open Market | 1,557 | $762K | 2/17/2026 |
| Ourania Tatsis | ▲ Buy | Grant | 5,789 | $0 | 2/17/2026 |
| Amit Sachdev | ▲ Buy | Grant | 5,789 | $0 | 2/17/2026 |
| Charles F. Wagner Jr. | ▼ Sell | Tax Withholding | 2,294 | $1.1M | 2/17/2026 |
| Charles F. Wagner Jr. | ▲ Buy | Grant | 7,365 | $0 | 2/17/2026 |
| Charles F. Wagner Jr. | ▼ Sell | Tax Withholding | 4,565 | $2.2M | 2/13/2026 |
| Ourania Tatsis | ▼ Sell | Tax Withholding | 3,804 | $1.9M | 2/13/2026 |
| Kristen Ambrose | ▼ Sell | Tax Withholding | 1,393 | $679K | 2/13/2026 |
| Ourania Tatsis | ▼ Sell | Open Market | 1,500 | $750K | 2/13/2026 |
| Amit Sachdev | ▼ Sell | Tax Withholding | 3,548 | $1.7M | 2/13/2026 |
| Duncan McKechnie | ▼ Sell | Tax Withholding | 2,283 | $1.1M | 2/13/2026 |
| Reshma Kewalramani | ▼ Sell | Tax Withholding | 13,041 | $6.4M | 2/13/2026 |
| Mark E. Bunnage | ▼ Sell | Tax Withholding | 2,283 | $1.1M | 2/13/2026 |
| Carmen Bozic | ▼ Sell | Tax Withholding | 3,804 | $1.9M | 2/13/2026 |
| Biller Jonathan | ▼ Sell | Tax Withholding | 2,993 | $1.5M | 2/13/2026 |
| Biller Jonathan | ▼ Sell | Open Market | 988 | $493K | 2/13/2026 |
| Sangeeta N. Bhatia | ▼ Sell | Open Market | 266 | $133K | 2/13/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Tax Withholding | 1,903 | $928K | 2/13/2026 |
| Kristen Ambrose | ▼ Sell | Open Market | 1,376 | $634K | 2/11/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Open Market | 1,751 | $806K | 2/11/2026 |
| Ourania Tatsis | ▼ Sell | Open Market | 466 | $215K | 2/11/2026 |
| Mark E. Bunnage | ▼ Sell | Open Market | 2,021 | $931K | 2/11/2026 |
| Biller Jonathan | ▼ Sell | Open Market | 1,925 | $886K | 2/11/2026 |
| Kristen Ambrose | ▼ Sell | Tax Withholding | 592 | $277K | 2/10/2026 |
| Charles F. Wagner Jr. | ▼ Sell | Tax Withholding | 3,045 | $1.4M | 2/10/2026 |
| Ourania Tatsis | ▼ Sell | Tax Withholding | 2,140 | $1.0M | 2/10/2026 |
| Amit Sachdev | ▼ Sell | Tax Withholding | 2,057 | $964K | 2/10/2026 |
| Duncan McKechnie | ▼ Sell | Tax Withholding | 1,127 | $528K | 2/10/2026 |
| Mark E. Bunnage | ▼ Sell | Tax Withholding | 1,127 | $528K | 2/10/2026 |
| Carmen Bozic | ▼ Sell | Tax Withholding | 2,145 | $1.0M | 2/10/2026 |
| Biller Jonathan | ▼ Sell | Tax Withholding | 1,630 | $764K | 2/10/2026 |
| Atkinson Edward Morrow III | ▼ Sell | Tax Withholding | 872 | $408K | 2/10/2026 |
| Reshma Kewalramani | ▼ Sell | Tax Withholding | 8,297 | $3.9M | 2/10/2026 |
| LEIDEN JEFFREY M | ▲ Buy | Grant | 9,012 | $0 | 1/22/2026 |
| Amit Sachdev | ▲ Buy | Grant | 3,883 | $0 | 1/22/2026 |
| Reshma Kewalramani | ▲ Buy | Grant | 26,972 | $0 | 1/22/2026 |
| Carmen Bozic | ▲ Buy | Grant | 7,866 | $0 | 1/22/2026 |
| Charles F. Wagner Jr. | ▲ Buy | Grant | 4,160 | $0 | 1/22/2026 |
| Carmen Bozic | ▲ Buy | Grant | 3,467 | $0 | 1/22/2026 |
| Amit Sachdev | ▲ Buy | Grant | 7,866 | $0 | 1/22/2026 |
| Reshma Kewalramani | ▲ Buy | Grant | 11,885 | $0 | 1/22/2026 |
| Biller Jonathan | ▲ Buy | Grant | 2,774 | $0 | 1/22/2026 |
| Biller Jonathan | ▲ Buy | Grant | 6,294 | $0 | 1/22/2026 |
| Ourania Tatsis | ▲ Buy | Grant | 7,866 | $0 | 1/22/2026 |
| Duncan McKechnie | ▲ Buy | Grant | 4,720 | $0 | 1/22/2026 |
| Ourania Tatsis | ▲ Buy | Grant | 3,883 | $0 | 1/22/2026 |
| Charles F. Wagner Jr. | ▲ Buy | Grant | 9,440 | $0 | 1/22/2026 |
| Duncan McKechnie | ▲ Buy | Grant | 2,080 | $0 | 1/22/2026 |
| Atkinson Edward Morrow III | ▲ Buy | Grant | 3,934 | $0 | 1/22/2026 |
| Kristen Ambrose | ▲ Buy | Grant | 2,950 | $0 | 1/22/2026 |
| Kristen Ambrose | ▲ Buy | Grant | 1,300 | $0 | 1/22/2026 |
| ALTSHULER DAVID | ▲ Buy | Grant | 7,866 | $0 | 1/22/2026 |
| ALTSHULER DAVID | ▲ Buy | Grant | 3,328 | $0 | 1/22/2026 |
| Atkinson Edward Morrow III | ▲ Buy | Grant | 3,883 | $0 | 1/22/2026 |
| Ourania Tatsis | ▼ Sell | Open Market | 4,500 | $2.1M | 1/7/2026 |
| Charles F. Wagner Jr. | ▲ Buy | Option Exercise | 9,532 | $1.8M | 1/6/2026 |
| Charles F. Wagner Jr. | ▼ Sell | Open Market | 9,532 | $4.4M | 1/6/2026 |
| LEIDEN JEFFREY M | ▲ Buy | Option Exercise | 1 | $91 | 12/4/2025 |
| Charles F. Wagner Jr. | ▼ Sell | Open Market | 7,000 | $3.2M | 12/3/2025 |
| Ourania Tatsis | ▼ Sell | Open Market | 4,500 | $2.0M | 12/3/2025 |
| LEIDEN JEFFREY M | ▲ Buy | Option Exercise | 63,781 | $5.5M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 4,352 | $1.9M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 2,320 | $1.0M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 5,809 | $2.6M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 15,681 | $7.1M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 10,360 | $4.7M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 1,152 | $515K | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 4,469 | $2.0M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 7,899 | $3.5M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 2,070 | $942K | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 2,469 | $1.1M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 5,880 | $2.6M | 12/3/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 1,320 | $582K | 12/3/2025 |
| Charles F. Wagner Jr. | ▼ Sell | Open Market | 7,000 | $3.2M | 12/3/2025 |
| Biller Jonathan | ▼ Sell | Open Market | 347 | $156K | 12/3/2025 |
| Lloyd Carney | ▼ Sell | Gift | 800 | $0 | 11/19/2025 |
| Atkinson Edward Morrow III | ▼ Sell | Open Market | 2,500 | $1.1M | 11/17/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 40 | $18K | 11/14/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 21,330 | $9.4M | 11/14/2025 |
| LEIDEN JEFFREY M | ▲ Buy | Option Exercise | 13,835 | $1.3M | 11/14/2025 |
| LEIDEN JEFFREY M | ▲ Buy | Option Exercise | 39,769 | $3.4M | 11/14/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 32,234 | $14.2M | 11/14/2025 |
| LEIDEN JEFFREY M | ▲ Buy | Option Exercise | 19,688 | $1.8M | 11/13/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 18,528 | $8.2M | 11/13/2025 |
| LEIDEN JEFFREY M | ▼ Sell | Open Market | 1,160 | $512K | 11/13/2025 |
| Biller Jonathan | ▼ Sell | Open Market | 694 | $281K | 10/2/2025 |
| Biller Jonathan | ▼ Sell | Tax Withholding | 1,259 | $504K | 10/1/2025 |
| Sangeeta N. Bhatia | ▼ Sell | Open Market | 266 | $103K | 8/27/2025 |
| Reshma Kewalramani | ▲ Buy | Open Market | 5,710 | $2.2M | 8/6/2025 |
| SACHS BRUCE I | ▲ Buy | Open Market | 1,634 | $636K | 8/6/2025 |
| SACHS BRUCE I | ▲ Buy | Open Market | 3,366 | $1.3M | 8/6/2025 |
| Reshma Kewalramani | ▲ Buy | Open Market | 4,290 | $1.7M | 8/6/2025 |
| Stuart A. Arbuckle | ▼ Sell | Tax Withholding | 37,243 | $16.8M | 7/1/2025 |
| ALTSHULER DAVID | ▼ Sell | Open Market | 52 | $22K | 5/15/2025 |
| Stuart A. Arbuckle | ▲ Buy | Grant | 37,622 | $0 | 5/13/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Vertex Highlights Sickle Cell Gene Therapy and Hormone Disorder Expansion
Vertex Pharmaceuticals is advancing a gene therapy for sickle cell disease, which could broaden its treatment portfolio but faces access challenges. The company also signals a potential new growth area in hormone disorders, moving beyond cystic fibrosis. With earnings approaching, investors are watching how these developments affect the company’s outlook. The stock has risen above the market recently, reflecting positive sentiment.
Vertex Highlights Sickle Cell Gene Therapy and Hormone Disorder Expansion. Vertex Pharmaceuticals is advancing a gene therapy for sickle cell disease, which could broaden its treatment portfolio but faces access challenges. The company also signals a potential new growth area in hormone disorders, moving beyond cystic fibrosis. With earnings approaching, investors are watching how these developments affect the company’s outlook. The stock has risen above the market recently, reflecting positive sentiment.